Barely Significant

Excerpts

514,629 sentences

borderline significantP = 0.0410.8× alphagold
Within the group of women with silicone implants and CTD (Group 1), between those women with paraproteins and those women without paraproteins there were only borderline significant differences or no significant differences (Mann–Whitney U test) in age (55.6 years versus 49.3 years, P = 0.041), in duration of CTD (10.4 versus 6.4 years, P = 0.051), in implant duration (10.2 years versus 12.5 years, P = 0.267), and in duration of silicone exposure (16.1 years versus 15.4 years, P = 0.783).
After 3 years' median follow-up, the PFS difference between atezolizumab and placebo did not reach statistical significance in the ITT (hazard ratio [HR], 0.83; 95% CI, 0.69 to 0.99; P = .041; median 13.5 v 11.3 months, respectively) or PD-L1–positive (HR, 0.86; 95% CI, 0.63 to 1.16; P = .30; median 15.2 v 13.1 months, respectively) populations.
nominally significantp = 0.0410.8× alphagold
The prespecified MCI group (MMSE >26, N = 125) showed nominally significant positive effects on ADAS-Cog13 (52%, nominal p = 0.041) and DAD (96%, nominal p = 0.016), positive trend on CDR-SB (102%, nominal p = 0.053), with significant hippocampal atrophy slowing (26%, p = 0.004), and positive grey/white matter effects on MRI-DTI.
marginally significantp =0.04100.8× alphagold
Although the investigated polymorphisms were not related to demographic features, clinicopathological lung tumour characteristics, or blood morphology indices, marginally significant correlations were found with some variables: C1236T with age of disease onset ( p =0.0410); C3435T with smoking status ( p =0.0561).
a strong trendp = .0410.8× alphagold
In the observation group, we found favorable prognostic effects of low MUC1 expression (HR for DFS: 0.55; 95% CI 0.29 to 1.04, p = .062; HR for OS: 0.35, 95% CI 0.18 to 0.68, p = .001) as well as a strong trend for improved survival in the gemcitabine group (HR for DFS: 0.48; 95% CI 0.24 to 0.96, p = .041; HR for OS: 0.56, 95% CI 0.28 to 1.11, p = .093), see Figures 3E–H : Survival analyses in subgroups for gemcitabine vs. observation.
failed to reach significancep = 0.0410.8× alpha
Changes in JOA and SF-36 failed to reach significance between two groups, while preoperative NDI in the high SCA category was larger than the low SCA category (23.33 ± 5.70 vs 19.32 ± 4.92, p = 0.041). △NDI (pre vs post) and △NDI (pre vs F/U) in the high SCA group exceeded than that in the low SCA group (pre vs post: p = 0.018, pre vs F/U: p = 0.048) (Table 3 ).
showed a trendP = 0.0410.8× alpha
Results A univariate analysis showed that CD133 expression in male patients at the late stage (II and III) was significantly associated with worse progression-free survival (PFS) ( P = 0.0057) and overall survival (OS) ( P = 0.015), and a multivariate analysis showed a trend toward worse OS ( P = 0.041).
a decreasing trendp=0.0410.8× alphagold
When stratified analysis was carried out in the group aged 8–10 years old, the children in 2015–2017 reported significantly lower summed scores on items belonging to factor III compared with peers in 2008–2011, while no significant differences were seen in items for the other three factors, indicating a decreasing trend in anxiety levels over time for the ‘less invasive procedures’ items (factor III) ( table 5 , p=0.041).
marginally significantP = 0.0410.8× alphagold
In the relative log(biomass) model (also R 2 = 0.10), the interaction between seed mass and the squared term for heterospecific density was marginally significant ( P = 0.041, Table 4 ) and indicated that light-seeded species exhibited a shallow hump-shaped relationship with heterospecific density whereas heavy-seeded species exhibited a shallow U-shaped relationship (Fig.